Skip to NavigationSkip to content

News

0
Novo Nordisk's oral semaglutide reduced blood sugar (HbA1c) levels and assisted weight loss to a greater degree than placebo over 26 weeks of...
0
NHS Providers, the membership organisation and trade association for professionals working in the NHS, has warned that the NHS is unprepared for...
0
AstraZeneca's Tagrisso has been approved in Japan as a first-line therapy in patients with inoperable or recurrent epidermal growth factor...
0
A further six senior officials from the China Food and Drug Administration (CFDA) have been fired in relation to the Changsheng Biotechnology...

Features

Pharmafocus caught up with Sensorion CEO Nawal Ouzren to take a look at her path throughout her career and get her advice on replicating the...